Search Results 91-100 of 16014 for melatonin receptor agonists

  1. Publications - Rozalina G. McCoy, M.D., M.S. - Mayo Clinic

    Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review. Thyroid. 2024 Apr; 34 (4):403-418 Epub 2024 Mar 26. View PubMed; McCoy RG ...

  2. Mayo Clinic expert responds to new Type 2 diabetes guidelines

    Furthermore, by confining the recommendations to oral medications, another class of injectable medication – glucagon-like peptide-1 receptor agonists - is ...

  3. A Study to Evaluate the Safety, Tolerability, and Effectiveness of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis - Mayo Clinic

    ... receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis. Trauner M. Michael; Chung C. Chuhan; Sterling K. Kate; Liu X ...

  4. A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours - Mayo Clinic

    A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid ...

  5. TransCon (TC) TLR7/​8 Agonist, TC IL-2 β/​γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201) - Mayo Clinic

    TransCon (TC) TLR7/​8 Agonist, TC IL-2 β/​γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201) · Overview.

  6. A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure - Mayo Clinic

    In blocking the TRPV4 ion channel and reducing pulmonary interstitial fluid, GSK2798745 may improve pulmonary function, respiration, and gas exchange as well as ...

  7. Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism - Mayo Clinic

    This study is designed to answer the question as to whether the sympathetic nervous system is an important determinant of bone metabolism in humans.

  8. REM sleep behavior disorder - Doctors and departments - Mayo Clinic

    REM sleep behavior disorder is a sleep disorder in which you physically and vocally act out vivid, often unpleasant dreams during REM sleep.

  9. Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by ...

  10. Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension - Mayo Clinic

    ... receptor agonists (eg, selexipag) are permitted if stopped 24 hours prior to the start of study drug administration. - Any new ventricular or ...